The new framework is intended to make postmarket changes easier for medical devices. Experts recommend having a clear roadmap and contacting regulators early.

Q4 2024 Earnings Call Transcript March 24, 2025 Operator: Hello, and welcome to the Moleculin Biotech Fourth Quarter and Full ...

Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN) ("Erdene" or the "Company") is pleased to announce operating and ...

Many systems in nature—and in society—can suddenly change their properties: Water freezes at normal pressure at 32°F, a power ...

Additional alignment with FDA on LX2006 planned pivotal study including protein expression co-primary endpoint: based on improvements in LVMI ...

The Hagerstown City Council will host a public hearing Tuesday evening about a proposed zoning change to allow a mixed-use ...

Developers also believed the small size of the apartments and accompanying “chalet” homes — 44 duplexes and 18 three-plexes — ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported ...

Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with chemotherapy in first-line pancreatic cancer - - Announced ...

Strategic L&D teams align learning with organizational priorities to ensure initiatives drive measurable business results.

Japan and Brazil are in the final stages of coordination to reach an agreement on reciprocal biennial visits by their leaders ...

Israel launched airstrikes across the Gaza Strip early Tuesday, killing more than 400 Palestinians, local health officials ...